Compounds > remoxipride
Page last updated: 2024-08-23

remoxipride and Disease Models, Animal

remoxipride has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Cools, AR; Ellenbroek, BA; van der Elst, MC; Wunderink, YS1
Clinckers, R; Ebinger, G; Meurs, A; Michotte, Y; Smolders, I1
Drukarch, B; Goosen, C; Sahadat, MC; Stoof, JC; Vermeulen, RJ; Wolters, EC1
Casey, DE; Gerlach, J1

Other Studies

5 other study(ies) available for remoxipride and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
    Psychopharmacology, 2007, Volume: 190, Issue:1

    Topics: alpha-Methyltyrosine; Amphetamine; Animals; Apomorphine; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Inhibition, Psychological; Injections, Intraperitoneal; Male; Neurons; Rats; Rats, Inbred Strains; Reflex, Startle; Remoxipride; Reserpine; Schizophrenic Psychology

2007
Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
    The European journal of neuroscience, 2007, Volume: 26, Issue:11

    Topics: Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Epilepsy; Ethylenediamines; Hippocampus; Male; Microdialysis; Neuropeptide Y; Pilocarpine; Rats; Rats, Wistar; Receptors, sigma; Remoxipride; Severity of Illness Index; Sigma-1 Receptor; Time Factors

2007
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.
    European journal of pharmacology, 1993, Apr-22, Volume: 235, Issue:1

    Topics: Analysis of Variance; Animals; Benzazepines; Disease Models, Animal; Dopamine Agents; Ergolines; Macaca mulatta; Male; Motor Activity; MPTP Poisoning; Parkinson Disease; Quinpirole; Remoxipride

1993
Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys.
    Progress in neuro-psychopharmacology & biological psychiatry, 1990, Volume: 14, Issue:1

    Topics: Animals; Antipsychotic Agents; Arousal; Benzamides; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Haloperidol; Male; Motor Activity; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride

1990